therapists to focus on more hands modalities. As they collect more data, the software will transition into an AI-based system to assess and assigns training protocols optimized for each patient’s deficit. The improved outcomes will allow clinics to provide reimbursable therapy using existing CPT codes for gait training on a patient base they currently have no treatment for. The device will be registered with the FDA as a Class 1 Exercise Device; and so, it can be sold and used WITHOUT FDA APPROVAL. Allowing NextStep Robotics to immediately generate revenue through: 1) Direct sales/leasing of robots; 2) Subscription to software service; 3) Service contracts.